Dual and Triple Agonists in Treating Metabolic Liver Disease | Retatrutide News

Dual and triple agonists, including Retatrutide, are being explored for treating metabolic liver diseases. These agents may offer improved efficacy by t...
Clinical Trials · October 29, 2026